Related Experiment Video
Updated: Jun 9, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Analysis of Intestinal and Nasopharyngeal Microbiota of Children with Meningococcemia in Pediatric Intensive Care
Gurkan Bozan1, Vicente Pérez-Brocal2,3, Kaan Aslan4
1Pediatric Intensive Care Unit, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey.
Abstract:
Microbiota composition might play a role in the pathophysiology and course of sepsis, and understanding its dynamics is of clinical interest. Invasive meningococcal disease (IMD) is an important cause of community-acquired serious infection, and there is no information regarding microbiota composition in children with meningococcemia. In this study, we aimed to evaluate the intestinal and nasopharyngeal microbiota composition of children with IMD. Materials and Methods: In this prospective, multi-center study, 10 children with meningococcemia and 10 age-matched healthy controls were included. Nasopharyngeal and fecal samples were obtained at admission to the intensive care unit and on the tenth day of their hospital stay. The V3 and V4 regions of the 16S rRNA gene were amplified following the 16S Metagenomic Sequencing Library Preparation. Results: Regarding the alpha diversity on the day of admission and on the tenth day at the PICU, the Shannon index was significantly lower in the IMD group compared to the control group (p = 0.002 at admission and p = 0.001, on the tenth day of PICU). A statistical difference in the stool samples was found between the IMD group at Day 0 vs. the controls in the results of the Bray-Curtis and Jaccard analyses (p = 0.005 and p = 0.001, respectively). There were differences in the intestinal microbiota composition between the children with IMD at admission and Day 10 and the healthy controls. Regarding the nasopharyngeal microbiota analysis, in the children with IMD at admission, at the genus level, Neisseria was significantly more abundant compared to the healthy children (p < 0.001). In the children with IMD at Day 10, genera Moraxella and Neisseria were decreased compared to the healthy children. In the children with IMD on Day 0, for paired samples, Moraxella, Neisseria, and Haemophilus were significantly more abundant compared to the children with IMD at Day 10. In the children with IMD at Day 10, the Moraxella and Neisseria genera were decreased, and 20 different genera were more abundant compared to Day 0. Conclusions: We first found alterations in the intestinal and nasopharyngeal microbiota composition in the children with IMD. The infection itself or the other care interventions also caused changes to the microbiota composition during the follow-up period. Understanding the interaction of microbiota with pathogens, e.g., N. meningitidis, could give us the opportunity to understand the disease's dynamics.
Insights
This study reveals significant differences in gut and nasopharyngeal microbiota for children with invasive meningococcal disease (IMD). These changes may be linked to the infection or treatments, impacting disease understanding.
Area of Science:
- Microbiology
- Pediatric Infectious Diseases
- Genomics
Background:
- Microbiota composition is increasingly recognized for its role in sepsis pathophysiology.
- Invasive meningococcal disease (IMD) is a severe community-acquired infection, yet its association with microbiota in children remains unexplored.
- Understanding these dynamics is crucial for clinical insights into meningococcemia.
Purpose of the Study:
- To investigate the intestinal and nasopharyngeal microbiota composition in children diagnosed with IMD.
- To compare the microbiota of IMD patients with age-matched healthy controls.
- To analyze changes in microbiota during hospitalization.
Main Methods:
- Prospective, multi-center study involving 10 children with meningococcemia and 10 healthy controls.
- Collection of nasopharyngeal and fecal samples at admission and on day 10.
- 16S rRNA gene sequencing (V3-V4 regions) for microbiota analysis.
Main Results:
- Significantly lower alpha diversity (Shannon index) in IMD patients compared to controls at admission and day 10 (p=0.002, p=0.001).
- Distinct differences in fecal microbiota composition between IMD patients and controls (Bray-Curtis, Jaccard analyses; p=0.005, p=0.001).
- Increased abundance of *Neisseria* in nasopharynx of IMD patients at admission (p<0.001); decreased *Moraxella* and *Neisseria* by day 10. Significant shifts in other genera observed over time.
Conclusions:
- First evidence of altered intestinal and nasopharyngeal microbiota in children with IMD.
- Both infection and medical interventions contribute to microbiota alterations during hospitalization.
- Further research into microbiota-pathogen interactions, like with *N. meningitidis*, can elucidate disease mechanisms.
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Microbiota of the Respiratory Tract
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

